HY21 result impresses, Clover (ASX:CLV) share price up

The Clover Corporation Limited (ASX:CLV) share price is up 7% after the business reported its FY21 half-year result (HY21). 

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

The Clover Corporation Limited (ASX: CLV) share price is up 7% after the business reported its FY21 half-year result (HY21).

Why is the Clover share price going up?

The numbers reported by Clover weren’t exactly positive. Net sales revenue decreased by 21.7% to $29.4 million. Excluding the negative foreign currency exchange impacts, net sales revenue was $30.3 million.

Clover’s net profit after tax sank 45.8% to $2.5 million. However, excluding the Melody Dairy start-up costs and IP legal defence costs, it would have made an underlying net profit after tax of $3.3 million.

Why are things difficult?

Clover explained that it experienced tough trading conditions in the first half of FY21. The infant formula market has seen a shift in demand and the supply chain driven by COVID-19 restrictions and market conditions in China. Global infant formula manufacturers are adjusting their market response.

Even so, Clover revealed that it has retained and grown its customer base.

The daigou channel has caused an impact and there is minimal travel by Chinese and students which have slowed the ‘grey market’ importation of many products, including infant formula.

The local Chinese market has also become more competitive with local manufacturers competing on price and aggressive channel strategies.

Dividend

The Clover board decided to declare a dividend of 0.5 cents per share.

Outlook

Clover stated that the fundamentals of the business remain strong with opportunities for growth across markets and segments currently impacted by COVID-19. The global uncertainty is leading to a slow recovery in the infant formula market and Clover has forecast FY21 revenue to be in the range of $60 million to $70 million.

Is the Clover share price a buy opportunity?

This seems like the type of problem that’s affecting businesses like A2 Milk Company Ltd (ASX: A2M), Synlait Milk Ltd (ASX: SM1) and Bubs Australia Ltd (ASX: BUB).

At some point the infant formula sector could bounce back, which would benefit Clover (and the others).

The Clover share price is down a long way from where it was in the middle of 2020. It seems like an interesting business, but it’s not one I’m looking to add to my own portfolio right now because I’m not sure how big of an opportunity the business is.

CSL, Xero, ANZ... the ASX is beaten up

Right now, only brave investors are buying. Is ASX Reporting Season your KEY opportunity to act? Buy, or sell.

This coming Monday night, our two most experienced professional investors, Owen Rask and Leigh Gant, are hosting an exclusive and rare webinar on the what to watch this ASX reporting season. LIVE and free

With over 35 years of combined investing experience, join our Chief Investment Officer and Head of Content for our free Q&A.

We’ll be diving into results from CSL, Pro Medicus (ASX: PME), ANZ Bank and more. It’s absolutely free to join us. Take advantage of this volatility with our free playbook. Simply click here to view the topics.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.